Facial angiofibromas of tuberous sclerosis treated with topical sirolimus in an Indian patient
Facial angiofibromas are the most visible and unsightly of all the cutaneous manifestations of tuberous sclerosis (TSC). A 17-year-old female, a known case of TSC, presented for the treatment of cosmetically disfiguring facial angiofibromas. She was started on twice daily application of 0.1% sirolim...
Main Author: | Resham J Vasani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=2;spage=165;epage=169;aulast=Vasani |
Similar Items
-
Topical sirolimus in facial angiofibroma
by: Prachi Chetankumar Gajjar, et al.
Published: (2018-01-01) -
Topical rapamycin (sirolimus) for facial angiofibromas
by: Bhushan Madke
Published: (2013-01-01) -
Use of topical rapamycin in facial angiofibromas in Indian skin type
by: Vishalakshi Viswanath, et al.
Published: (2016-01-01) -
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
by: Takashi Hatano, et al.
Published: (2020-06-01) -
Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex
by: Tohru Okanishi, et al.
Published: (2020-01-01)